We're trimming some more off a stock that's enjoying nice post-earnings gains

DuPont reported Q3 organic sales growth of 5% year over year and adjusted EPS of $2.09, beating the $1.87 consensus, and raised full-year guidance with an upbeat Q4 outlook. Shares gained 4% to about $147, after reaching $154 intraday; the article says the trust will sell 50 shares, leaving it with 400 and reducing the portfolio weighting to about 1.5% from 1.7%. The trust cites DuPont’s execution and free cash flow but says the next catalyst is unclear, and plans to lock in an approximately 58% gain on shares bought in August 2023.

Analysis

The beat supports a higher near-term earnings floor, but the harder question is whether execution can keep compounding once the guidance increase is fully priced. Broad end-market participation lowers reliance on any single demand driver; it does not, by itself, establish durable share gains or a new growth engine. The market’s next test is whether organic growth converts into sustained margin improvement and free cash flow—not just whether DuPont can repurchase shares. Buybacks can support per-share results, but are a weaker catalyst if operating momentum stalls.

Over days, the post-earnings gap may attract momentum buyers, while the retreat from the intraday high suggests some profit-taking risk. Over 1–3 months, Middle East-related water demand disruption and delivery against the raised outlook are the key checks. Over 6–18 months, the thesis depends on continued post-separation execution and cash generation. A contrarian risk is that investors extrapolate one strong quarter and guidance raise without a clearly identified next catalyst. Conversely, trimming too aggressively could miss further multiple support if margins and cash conversion continue to improve. The thesis weakens if subsequent organic growth or margins disappoint, guidance is cut, or free-cash-flow conversion fails to support the stated capital-return potential.

Key Decisions for Investors

• For existing holders, consider trimming a portion into the earnings-driven strength rather than treating the beat as a reason to add immediately; retain a core position while the raised outlook is tested.
• Avoid chasing the gap. Reassess for an add after the initial post-earnings volatility, contingent on confirmation in the next report that organic growth is translating into margins and free cash flow.
• No high-conviction short is warranted on this evidence alone. A tactical bearish view would require failed guidance delivery or weakening growth/margin indicators, not simply the absence of a newly announced catalyst.
• Watch the next quarterly report for organic growth by end market, margin progression, free-cash-flow conversion, buyback execution, and any persistence of Middle East disruption to water demand.